GHRS Short Volume
GH Research PLC (GHRS) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.93B, listed on NASDAQ, employing roughly 50 people, carrying a beta of 1.31 to the broader market. GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions. Led by Velichka Valcheva, public since 2021-06-25.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-06-30
- Short Volume
- 15.9K
- Total Volume
- 76.0K
- Short %
- 20.90%
- 30-Day Avg Short %
- 42.06%
Showing 30 days of FINRA short volume data for GH Research PLC.
Learn how short volume is reported and how to read the data →
Frequently asked GHRS short volume questions
- What is the daily GHRS short volume?
- As of Jun 30, 2026, GH Research PLC (GHRS) short volume is 15.9K shares against 76.0K total reported volume, or 20.90% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is GHRS short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does GHRS short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.